The deubiquitinase USP25 supports colonic inflammation and bacterial infection and promotes colorectal cancer
Author:
Funder
National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/s43018-020-0089-4.pdf
Reference58 articles.
1. Kaser, A., Zeissig, S. & Blumberg, R. S. Inflammatory bowel disease. Annu. Rev. Immunol. 28, 573–621 (2010).
2. Somineni, H. K. & Kugathasan, S. The microbiome in patients with inflammatory diseases. Clin. Gastroenterol. Hepatol. 17, 243–255 (2019).
3. Jostins, L. et al. Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119–124 (2012).
4. Hugot, J. P. et al. Association of Nod2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411, 599–603 (2001).
5. Ogura, Y. et al. A frameshift mutation in Nod2 associated with susceptibility to Crohn’s disease. Nature 411, 603–606 (2001).
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. E3 ubiquitin ligases and deubiquitinases in colorectal cancer: Emerging molecular insights and therapeutic opportunities;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-12
2. USP25 Promotes the Antimycobacterial Response of Macrophages Through Stabilizing B-Raf and C-Raf;The Journal of Infectious Diseases;2024-08-07
3. Deubiquitinase USP25 Alleviates Obesity-Induced Cardiac Remodeling and Dysfunction by Downregulating TAK1 and Reducing TAK1-Mediated Inflammation;JACC: Basic to Translational Science;2024-08
4. CDKL3 is a targetable regulator of cell cycle progression in cancers;Journal of Clinical Investigation;2024-07-04
5. ATXN3 functions as a tumor suppressor through potentiating galectin-9-mediated apoptosis in human colon adenocarcinoma;Journal of Biological Chemistry;2024-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3